Digital Health Global

DECEMBER 5, 2023

Despite a history of drug development failures in the field, recent work provides reason for optimism, showing a possible therapeutic arsenal to limit disease progression at an early stage.

Patient Experience 88

Patient Experience Digital Health Drug Development Healthcare Innovation 88

Digital Health Global

MARCH 26, 2024

BASEL, Switzerland–(BUSINESS WIRE)–Indivi, a leading MedTech company headquartered in Basel, Switzerland, has entered into an agreement with Biogen to advance digital health technology and develop digital biomarkers for Parkinson’s disease.

Health Technology 88

Health Technology Digital Health BioTech Drug Development 88

Digital Health Global

JANUARY 4, 2024

Koneksa’s innovative digital model aims to address limitations in existing functional status assessments by leveraging digital health technologies (DHTs) for both objective and self-reported outcomes. Chief Medical Officer, Koneksa. Chief Scientific Officer, Koneksa.

Digital Health 88

Digital Health Health Technology Drug Development healthcare technology 88

Digital Health Global

FEBRUARY 19, 2024

Biofourmis , a global digital health and clinical trial solutions leader, announces four key partnerships with top pharmaceutical firms. Beyond digital biomarker and endpoint expertise, pharmaceutical partners are leveraging Biofourmis to streamline study timelines through its Digital Clinical Trials solution.

Pharmaceuticals 166

Pharmaceuticals Leadership Drug Development Digital Health 166

Mobi Health News

JULY 15, 2021

Also: Entos works to improve drug development after closing its Series A round and Castor plans to build out its decentralized clinical trial platform with a $45 million investment.

Drug Development 210

Drug Development Digital Health 210

Digital Health Global

JANUARY 9, 2024

The investment adds to a growing list of prominent digital health investors in Europe and the United States, including Nina Capital and Young Sohn, a co-founder of Veeva Systems. The funding speaks to the global nature of pre-approval access and its increasing importance in the drug development process. “

Pharmaceuticals 88

Pharmaceuticals Drug Development Digital Health Health Technology 88

Digital Health Global

APRIL 5, 2024

Furthermore, the industry witnessed a decline in the average return on investment (ROI) for R&D to as low as 1.2%, and the peak sales per asset valued just above $350 million, indicating a need to build more efficient drug development processes with the implementation of newer technologies.

Drug Development 88

Drug Development Pharmaceuticals Digital Health Health Technology 88

Digital Health Global

SEPTEMBER 19, 2023

Among these transformative innovations, artificial intelligence (AI ) stands out as a major force, reshaping the fields of drug discovery , drug development, clinical trials and patient care. The clinical trials phase represents a crucial turning point in drug development, but is often characterised by inefficiencies and delays.

Pharmaceuticals 167

Pharmaceuticals Drug Development Digital Health 167

Digital Health Global

JANUARY 25, 2024

Biomarkers will help select patients whose cancer biologies are best suited to treatment with the right drug targeting the active disease mechanism. Debiopharm’s main activities include drug development, drug manufacturing and digital health investment.

Drug Development 88

Drug Development Digital Health 88

Digital Health Global

JUNE 13, 2023

“The utilization of evidence-based digital biomarkers is the key to transforming healthcare,” said Chris Benko, CEO, Koneksa. “We’re We’re on a mission to revolutionize drug development in clinical trials by harnessing the power of our digital solutions with real-time, data-driven insights.

Drug Development 88

Drug Development eMed BioTech Digital Health 88

Digital Health Global

MARCH 2, 2023

Koneksa’s digital biomarker solutions include an industry-leading platform that gives research sponsors and clinical sites the ability to seamlessly aggregate data in real-time from devices, ePROs, patient diaries, and clinical assessments to provide the full picture of an individual’s health.

Life Science 88

Life Science Drug Development BioTech Leadership 88

Digital Health Global

APRIL 16, 2024

A Tufts Center for the Study of Drug Development study shows that, on average, decentralized trials can achieve net financial benefits from five to 13 times for Phase II and Phase III trials, equating to roughly $10 million ROI and $39 million ROI for an investment on average of $500K in Phase II and $1.5M

Drug Development 88

Drug Development Pharmaceuticals Health science Digital Health 88

Digital Health Global

SEPTEMBER 28, 2023

The new seed funding activity will therefore pave the way for the next generation of treatments and digital health, providing healthcare professionals with better tools to improve experiences and outcomes for patients. Since 2017 Debiopharm has invested in 15 AI and digital health companies, typically leading the investment rounds.

Drug Development 88

Drug Development Pharmaceuticals Digital Health Life Science 88

Digital Health Global

JANUARY 8, 2024

A Tufts Center for the Study of Drug Development study shows that, on average, decentralized trials can achieve net financial benefits from five to 13 times for Phase II and Phase III trials, equating to roughly $10 million ROI and $39 million ROI respectively. Medable, which ranked in the top 8% of software companies on the 2023 Inc.

Life Science 88

Life Science Drug Development Pharmaceuticals HIPAA 88

Redox

SEPTEMBER 26, 2023

Top stories CMS creates all-payer model for states CMS is offering an all-payer funding opportunity of up to $12M for eight states to improve population health. Two trends might be changing the game for private clouds: 1) flat/increased pricing for the public cloud and 2) dropping data center costs.

FHIR 105

FHIR Drug Development Telehealth Digital Health 105

Digital Health Global

MAY 10, 2023

Enhancing outcomes for patients with the implementation of digital technologies, such as artificial intelligence (AI) and big data analysis, empowers healthcare professionals to make better-informed decisions. Artificial Intelligence is utilized in various areas of healthcare, ranging from drug development to medical image analysis.

Patient Experience 167

Patient Experience Mobile Health Telemedicine Drug Development 167

Digital Health Global

JUNE 20, 2023

Founded in 2018 and supported from the outset by LallianSe, the life sciences integrator, BrainTale has developed and commercializes an accessible, reliable and clinically validated brain measurement digital platform solution for drug developers and physicians – neurologists, neuroradiologists and intensivists.

Life Science 88

Life Science Drug Development BioTech Pharmaceuticals 88

Digital Health Global

SEPTEMBER 27, 2023

About Automera Automera is an early-stage company focused on the development of a novel therapeutic approach via autophagy-based targeted protein degradation. ClavystBio was conceived and launched by Temasek to be a venture builder, trusted partner, and keystone to catalyze global health solutions from Singapore.

Life Science 88

Life Science Drug Development HC BioTech 88

Digital Health Global

JANUARY 31, 2024

A Tufts Center for the Study of Drug Development study shows that, on average, decentralized trials can achieve net financial benefits from five to 13 times for Phase II and Phase III trials, equating to roughly $10 million ROI and $39 million ROI for an investment of on average of $500K in Phase 2 and $1.5M in Phase 3.

Health science 88

Health science Drug Development Digital Health Patient Experience 88

Lloyd Price

NOVEMBER 21, 2023

Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Email lloyd@nelsonadvisors.co.uk Subscribe Today! Buy, build or partner?

Drug Development 70

Drug Development Health science healthcare technology Leadership 70

Lloyd Price

JUNE 17, 2023

The market for digital health is maturing. When the Teladoc Livongo merger was announced in 2020, the market for digital health was still in its early stages. However, the market has matured since then, and there are now a number of other digital health companies competing with Teladoc.

Digital Health 81

Digital Health Drug Development Telemedicine Telehealth 81

Digital Health Global

NOVEMBER 2, 2023

Wearable monitoring devices, genomics, and AI play vital roles in this transformation, enabling personalized interventions and collective health data sharing for research. Drug development The traditional drug discovery process is characterized by its protracted timeline, high costs, and significant attrition rates among drug candidates.

Drug Development 88

Drug Development Pharmaceuticals Public Health Telehealth 88

Health Populi

APRIL 29, 2019

In the past couple of months, Amazon announced many health-related plans and developments, including: Accepting medical and health savings accounts (HSAs) to pay for consumer health products like over-the-counter drugs. See more on that recommendation, and subsequent social media frenzy, here on Health Populi ).

HIPAA 305

HIPAA Drug Development Digital Health Mental health 305

Lloyd Price

DECEMBER 11, 2023

The WHO and the India G20 presidency emphasised its importance by launching ‘The Global Initiative of Digital Health’ (GIDH) in August, proclaiming: “Digital health is a proven accelerator to advance health outcomes and achieve Universal Health Coverage and health-related Sustainable Development Goals.”

Pharmaceuticals 64

Pharmaceuticals Digital Health Drug Development Life Science 64

Healthcare IT Today

AUGUST 7, 2022

Data platform H1 is teaming with Lokavant , a clinical trial analytics vendor, to help clinical trial teams determine the best sites for trials in an effort to accelerate drug development.

eCare 85

eCare Digital Health Drug Development Healthcare IT 85

Healthcare IT Today

NOVEMBER 1, 2022

Deerfield invests across the life science, medical device, diagnostic, digital health, and health service industries at every stage of evolution. The company will use this new funding to further expand its real-world data platform and services in order to drive more efficient and inclusive drug development in oncology.

Life Science 84

Life Science Drug Development Digital Health Health IT 84

Digital Health Global

FEBRUARY 16, 2023

Their expertise in company building, capital formation, and drug development will be a tremendous resource to Avilar as the innovation leader in the new field of extracellular protein degradation.” Find out more: www.sanofiventures.com.

Life Science 88

Life Science BioTech Drug Development Digital Health 88

Healthcare IT News - Telehealth

MAY 29, 2020

“These technologies can also be leveraged by pharmaceutical companies to monitor the results of the drugs developed by them," said Ashish Kaul, technical insights senior research analyst at Frost & Sullivan. THE LARGER CONTEXT. She cites examples such as Binah.ai

Mental health 140

Mental health Drug Development Pharmaceuticals Telehealth 140

Digital Health Today

SEPTEMBER 6, 2019

In her role, she is responsible for finding use cases to apply digital solutions and services across the business and bring efficiencies that save time, lower costs and open up new business channels for Almirall. How to define and win buy-in of ‘Digital Transformation' within pharma companies. Digital Health Events.

Digital Health 66

Digital Health Drug Development Pharmaceuticals 66

Digital Health Global

NOVEMBER 30, 2023

Digital Health Technologies ( DHTs ) have revolutionized the landscape of clinical trials, particularly in neurology research, by enabling the collection of real-world data outside traditional clinical settings.

Health Technology 157

Health Technology Digital Health Life Science BioTech 157

Digital Health Global

APRIL 10, 2023

Aviceda Glycotech looks forward to this collaboration aimed at developing the next generation of cancer checkpoint immune therapeutics in Belfast. “It Co-Founder & President, and Chief Executive Officer.

Life Science 88

Life Science BioTech Drug Development Health science 88

Lloyd Price

FEBRUARY 18, 2024

Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today!

Pharmaceuticals 64

Pharmaceuticals healthcare technology Digital Health Leadership 64

Society for Participatory Medicine

JANUARY 27, 2022

Clinical trials, care encounters, and access to data were found guilty of not meeting patients where they are and not adequately addressing the social determinant of health factors, creating barriers for patients. Market forces drove acceleration in digital health, specifically telemedicine, which were sorely needed for several years.

BioTech 110

BioTech Life Science Drug Development Patient Experience 110

Lloyd Price

FEBRUARY 20, 2020

At Mangrove, we believe digital health represents one of the very largest opportunities for value creation. It will also explain the value of clinically- proven software interventions, while dispelling the myth that doctors are better placed to build digital health businesses.

mHealth 83

mHealth Drug Development Digital Health 83

Digital Health Global

MARCH 16, 2023

About Wellington Partners Wellington Partners is a leading European venture capital firm investing in the most promising early- and growth stage life science companies in the fields of biotechnology, therapeutics, medical technology, diagnostics and digital health. With funds totaling more than €1.2 Forbion manages well over EUR 2.3

Life Science 88

Life Science Pharmaceuticals BioTech Drug Development 88

Lloyd Price

FEBRUARY 18, 2024

Visit [link] HealthTech Corporate Development - Buy Side, Sell Side, Growth & Strategy services for Founders, Owners and Investors. Email lloyd@nelsonadvisors.co.uk HealthTech M&A Newsletter from Nelson Advisors - HealthTech, Health IT, Digital Health Insights and Analysis. Subscribe Today! Subscribe Today!

Pharmaceuticals 60

Pharmaceuticals healthcare technology Leadership Drug Development 60

Digital Health Global

NOVEMBER 20, 2023

–(BUSINESS WIRE)–AstraZeneca today launches Evinova, set to be a leading provider of digital health solutions to better meet the needs of healthcare professionals, regulators and patients. in 2060.

Life Science 88

Life Science Digital Health Drug Development Patient Experience 88